Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy

BACKGROUND: Maspin, a non-inhibitory member of the serine protease inhibitor superfamily, has been characterized as a tumor suppressor gene in multiple cancer types. Chemotherapeutic insensitivity is one of major obstacles to effectively treating muscle invasive bladder cancer (MIBC). This study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jinbo, Wang, Long, Tang, Yunhua, Gong, Guanghui, Liu, Longfei, Chen, Minfeng, Chen, Zhi, Cui, Yu, Li, Chao, Cheng, Xu, Qi, Lin, Zu, Xiongbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702361/
https://www.ncbi.nlm.nih.gov/pubmed/26733306
http://dx.doi.org/10.1186/s13046-015-0282-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4702361/
https://www.ncbi.nlm.nih.gov/pubmed/26733306
http://dx.doi.org/10.1186/s13046-015-0282-y

Ejemplares similares